SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
27 hedge funds and large institutions have $71.9M invested in Sierra Oncology, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $81.9M → $71.9M (-$9.98M)
Holders
27
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$3.25M | |
| 2 | +$405K | |
| 3 | +$201K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$111K |
| 5 |
Morgan Stanley
New York
|
+$105K |
Top Sellers
| 1 | -$4.58M | |
| 2 | -$189K | |
| 3 | -$77.7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$60.4K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$1K |